New recommendations for workplace chemical risk assessment published

The Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area of the DFG has now published the English version of its latest research-based recommendations on the risk assessment of substances used at the workplace.

Boston Scientific acquires Axonics, urology company, for $3.7 billion

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion. It’s the

January 8, 2024

AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance

What You Should Know: – AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA

August 23, 2024

ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody – Pharmaceutical Technology

Merus’s bispecific antibody petosemtamab targets epidermal growth factor receptor (EGFR) and leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5). Credit: MacroEcon via Shutterstock. Amongst abstracts announced

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.